Thus our objective was to determine if vaccination with any of the Mam-A epitope cDNA constructs would result in a more effective and prolonged CD8 CTL response against breast cancer cells and if not, could a single low dose of irradiation be used in combination with adoptive therapy to induce an effective and sustainable anti-tumor immune response. The gene discussed is CD8A; the disease is breast carcinoma.